Epigenetics : New Tool For Precision Medicine

On June 27, four new papers, co-published by several BLUEPRINT members and others in Nature Biotechnology and Nature Communications, mark the feasibility of epigenetic analysis for clinical diagnostics and precision medicine.

Epigenetic changes occur in all cancers, and in various other diseases. Measuring these changes provides unprecedented insights into the disease mechanisms at work in individual patients, which is important for better diagnosis and patient-specific treatment decisions

In this series of four papers, led by Christoph Bock (CeMM Research Center for Molecular Medicine of the Austrian Academy of Science Vienna) and Stephan Beck (University College London (UCL)), an international group of scientists have validated the feasibility of epigenetic analysis for clinical application.